| Dr William L Carroll, MD | |
|
1240 Wrights Ln, West Chester, PA 19380-4252 | |
| (610) 431-1210 | |
| (610) 594-2625 |
| Full Name | Dr William L Carroll |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1240 Wrights Ln, West Chester, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366422057 | NPI | - | NPPES |
| 001608759 | Medicaid | PW |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD046259L (Pennsylvania) | Primary |
| Entity Name | Gateway Medical Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770659476 PECOS PAC ID: 5294707634 Enrollment ID: O20040806001106 |
News Archive
Researchers from Uppsala University have studied beta cells of type-2 diabetic donors, and find that a mislocalized calcium channel contributes to the failed insulin secretion associated with the disease.
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that ALUNBRIG (brigatinib) has received Accelerated Approval from the U.S. Food and Drug Administration for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer who have progressed on or are intolerant to crizotinib.
Sanjay Gupta, PhD, of Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center will receive $962,000 over three years to investigate drug resistance mechanisms in prostate cancer.
According to a new study from Norway up to a fourth of breast cancers found through mammograms are harmless and would not cause noticeable disease during the women's lifetimes. Such women are said to be over-diagnosed, because their cancers would not have caused symptoms or death. Over-diagnosis is a problem because women may receive tests and treatment they did not actually need.
› Verified 3 days ago
| Entity Name | Melmark, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861568107 PECOS PAC ID: 6507838836 Enrollment ID: O20040809000308 |
News Archive
Researchers from Uppsala University have studied beta cells of type-2 diabetic donors, and find that a mislocalized calcium channel contributes to the failed insulin secretion associated with the disease.
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that ALUNBRIG (brigatinib) has received Accelerated Approval from the U.S. Food and Drug Administration for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer who have progressed on or are intolerant to crizotinib.
Sanjay Gupta, PhD, of Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center will receive $962,000 over three years to investigate drug resistance mechanisms in prostate cancer.
According to a new study from Norway up to a fourth of breast cancers found through mammograms are harmless and would not cause noticeable disease during the women's lifetimes. Such women are said to be over-diagnosed, because their cancers would not have caused symptoms or death. Over-diagnosis is a problem because women may receive tests and treatment they did not actually need.
› Verified 3 days ago
| Entity Name | Pentahealth, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639787740 PECOS PAC ID: 9537586672 Enrollment ID: O20200903000805 |
News Archive
Researchers from Uppsala University have studied beta cells of type-2 diabetic donors, and find that a mislocalized calcium channel contributes to the failed insulin secretion associated with the disease.
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that ALUNBRIG (brigatinib) has received Accelerated Approval from the U.S. Food and Drug Administration for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer who have progressed on or are intolerant to crizotinib.
Sanjay Gupta, PhD, of Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center will receive $962,000 over three years to investigate drug resistance mechanisms in prostate cancer.
According to a new study from Norway up to a fourth of breast cancers found through mammograms are harmless and would not cause noticeable disease during the women's lifetimes. Such women are said to be over-diagnosed, because their cancers would not have caused symptoms or death. Over-diagnosis is a problem because women may receive tests and treatment they did not actually need.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William L Carroll, MD 412 Creamery Way, Suite 400, Exton, PA 19341-2551 Ph: (610) 594-7590 | Dr William L Carroll, MD 1240 Wrights Ln, West Chester, PA 19380-4252 Ph: (610) 431-1210 |
News Archive
Researchers from Uppsala University have studied beta cells of type-2 diabetic donors, and find that a mislocalized calcium channel contributes to the failed insulin secretion associated with the disease.
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that ALUNBRIG (brigatinib) has received Accelerated Approval from the U.S. Food and Drug Administration for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer who have progressed on or are intolerant to crizotinib.
Sanjay Gupta, PhD, of Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center will receive $962,000 over three years to investigate drug resistance mechanisms in prostate cancer.
According to a new study from Norway up to a fourth of breast cancers found through mammograms are harmless and would not cause noticeable disease during the women's lifetimes. Such women are said to be over-diagnosed, because their cancers would not have caused symptoms or death. Over-diagnosis is a problem because women may receive tests and treatment they did not actually need.
› Verified 3 days ago
Dr. Paul Debacco, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1161 Mcdermott Dr., Suite 101, West Chester, PA 19380 Phone: 610-701-7011 Fax: 610-429-5199 | |
Miss Sara Elizabeth Sterling, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 E Marshall St, West Chester, PA 19380 Phone: 610-431-5000 Fax: 610-431-5025 | |
Levelle Drose-bigatel, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1601 Mcdaniel Dr, Suite 50, West Chester, PA 19380 Phone: 484-905-8000 Fax: 484-905-8005 | |
Dr. George Nicholas Spyropoulos, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1646 W Chester Pike, Suite 12, West Chester, PA 19382 Phone: 610-738-9002 Fax: 610-738-9101 | |
Dr. Louis H Hirshberg, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1114 Lincoln Dr, West Chester, PA 19380 Phone: 610-608-4051 | |
Mary Brigandi, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 E Marshall St, West Chester, PA 19380 Phone: 610-431-5000 Fax: 610-738-2356 | |
Boyd C. Myers, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1240 Wrights Lane, West Chester, PA 19380 Phone: 610-431-1210 Fax: 610-594-2625 |